New York, NY - March 28, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday March 27th. The Nasdaq Composite fell 2.22 (0.07%) to close at 3,120.35.

 pSivida Corp. (NASDAQ: PSDV) continued to move higher and added another 36.45% to close at $2.50 after gaining over 12% in the previous trading session. The stock has been moving on expectations that Alimera Sciences' (Nasdaq: ALIM) ILLUVIEN would be approved in about seven European countries by the end of the quarter. pSivida would receive royalties on ILLUVIEN, about 20% of net profits which will be determined on a country-by-country basis.

Read more: Tuesday's NASDAQ Winners: PSDV, SCMF, HOGS, ISTA

What President Obama Didn’t Say about Rare Earths

“Being able to manufacture advanced batteries and hybrid cars in America is too important for us to stand by and do nothing. “Our competitors should be on notice: You will not get away with skirting the rules.”

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt

New York, NY - March 27 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the OTCBB for March 26th.

 Apollo Solar Energy, Inc. (OTC: ASOE) was the biggest percentage gainer moving 0.200 (133.33%) to close at $0.35 on over 19k shares - 16X its average volume. Apollo Solar Energy, Inc. (Apollo) is a vertically-integrated refiner of tellurium (Te) and high-purity tellurium-based metals for specific segments of the electronic materials market.

Read more: Monday's OTC Penny Stock % Winners: (OTC: ASOE), (OTC: SBFM), (OTC: NEOM) (OTC: MCLN)

New York, NY - March 27, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday March 26th. The Nasdaq Composite surged 54.65 (1.78%) to end at 3,122.57.

 SIGA Technologies, Inc. (NASDAQ: SIGA) shares soared 29.26% to close at $3.49 without any official news. The stock has been showing strong support at $2 and has jumped over 38% so far this year. Yesterday's volume was impressive with more than 2.95 million shares traded, compared to its average volume of 355K shares.

 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, used for weight control, in patients who are obese or overweight and have at least one weight-related co-morbid condition. Shares of the company gained 24.90% to $3.01 in the last trading session.

Read more: Monday's NASDAQ Winners: SIGA, ARNA, VRNM, GRVY

Critical Issues in Global Economics

Prepared for the
Federal Financial Institutions Examination Council
(FRB, FDIC, CFPB, OCC, NCUA, SLC)

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt